Navigation Links
NYC Medical Examiner Peforming Autopsy on Natasha Richardson
Date:3/19/2009

Brain hemorrhage might explain the actress' sudden death, doctors say

THURSDAY, March 19 (HealthDay News) -- With results of an autopsy on Natasha Richardson expected later Thursday, many are wondering how the acclaimed actress apparently suffered devastating brain damage after a seemingly minor fall on a beginner's ski slope in Canada.

The New York City medical examiner was performing the autopsy. The 45-year-old Richardson reportedly suffered a head injury after falling Tuesday during a private lesson at a resort in Quebec, according to the Associated Press.

"If you take the name Natasha Richardson out of the picture and ask how a neurosurgeon would think of a case where someone has a fall which seems fairly minor and then deteriorates a few hours later, quite a few things would go through the surgeon's differential thinking," explained Dr. Arno Fried, chairman of neurosurgery at Hackensack University Medical Center in New Jersey. "It's not an uncommon scenario."

A worse-case scenario would be bleeding either on the surface or deep inside the brain, Fried said.

And this does fit with many of the details of Richardson's accident that are known at this time. According to news reports, the award-winning actress fell during a beginner skiing lesson Tuesday afternoon at the Mont Tremblant ski resort north of Montreal. She was not wearing a helmet.

Richardson suffered no immediately apparent injuries and was able to walk and talk right after the accident. "She was awake and alive and laughing and breathing," Catherine Lacasse, the public relations supervisor for Mont Tremblant Resorts, told Bloomberg News. "She refused to see a doctor. She said she was fine and everything was OK."

However, Richardson reported a headache about an hour after the mishap and her condition deteriorated. She was taken by ambulance to a nearby hospital, then transferred to Hopital du Sacre-Coeur
'/>"/>

Copyright©2009 ScoutNews,LLC.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Maryland We Work for Health Calls on Elected Officials to Focus on Medical Research and Innovation to Bolster Economy and Find Cures
2. China Information Security Technology, Inc. Announces that Its Medical Case Statistics Software Selected for Exclusive Contract
3. Abaxis, Inc. to Attend Lazard Capital Markets Medical Technologies Conference
4. The Department of Pain Medicine and Palliative Care at Beth Israel Medical Center is Named 2009 Center of Excellence Award Winner by the American Pain Society
5. Joan Gaeta Lung Cancer Foundation Donates $15,000 to Addario Lung Cancer Medical Institute (ALCMI) for Lung Cancer Research
6. Medical Data Systems, Inc. (MDS) Announces New Chief Operating Officer (COO)
7. Askesis Development Group, Inc. Launches New Behavioral Health Software for Electronic Medical Records (EMR) and Practice Management
8. Ongoing worldwide shortage of medical isotopes could threaten patient care, says expert
9. Arobella Medical Announces European CE Mark Approval of Qoustic Wound Therapy System(TM)
10. Greenway Medical Technologies Continues Fast-Paced Growth With Addition of Cardiovascular Specialty Associates of North Texas (CSANT)
11. New Electronic Medical Transcription Company Website Arrives
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... November 26, 2014 Increasing demand ... include image guided surgeries has paved way for ... Rising incidence of various types of cancers and ... increase in demand for these owing to their ... contrast media injectors market can also be attributed ...
(Date:11/26/2014)... November 26, 2014 German scientists say ... science can cause mesothelioma that looks and acts similar ... new article on the research. Click here to ... Institute for Toxicology and Experimental Medicine in Hannover injected ... all of the rats eventually developed mesothelioma , ...
(Date:11/26/2014)... November 26, 2014 For its ... published The AIS Report on Blue Cross and Blue ... Inc. on the varied strategies the two Blues plans ... compliance with treatments for sleep apnea, ranging from brick-and-mortar ... because it’s linked to increased rates of a variety ...
(Date:11/26/2014)... November 26, 2014 With Thousand Oaks ... dollars, the prosthodontists at the Anacapa Dental Art Institute in ... procedures can be daunting for some. , That is why ... procedures they offer. , “No dentist wants cost to come ... of teeth,” said Dr. Mamaly Reshad, partner in the Anacapa ...
(Date:11/26/2014)... 26, 2014 Sonru, the video interviewing ... Chief Operating Officer and Chief Marketing Officer, in addition ... , Jeff Jones has been appointed as Chief ... takes the role of Chief Marketing Officer. , Mr ... whose 25-year career includes senior roles with The Walt ...
Breaking Medicine News(10 mins):Health News:Contrast Media Injectors Market To 2020 - Global Industry, Growth, Size, Share, Trends, Analysis And Forecast To 2020 Research Report By Grand View Research, Inc. 2Health News:Contrast Media Injectors Market To 2020 - Global Industry, Growth, Size, Share, Trends, Analysis And Forecast To 2020 Research Report By Grand View Research, Inc. 3Health News:Multi-walled Nanotubes Linked to Mesothelioma in New Study, According to Surviving Mesothelioma 2Health News:AIS Newsletter Reports on Strategies Blues Plans Are Implementing to Combat Sleep Apnea 2Health News:AIS Newsletter Reports on Strategies Blues Plans Are Implementing to Combat Sleep Apnea 3Health News:Anacapa Dental Art Institute Doctors Offers 6 Tips on How to Pay for Cosmetic, Restorative and Implant Dentistry 2Health News:Anacapa Dental Art Institute Doctors Offers 6 Tips on How to Pay for Cosmetic, Restorative and Implant Dentistry 3Health News:Anacapa Dental Art Institute Doctors Offers 6 Tips on How to Pay for Cosmetic, Restorative and Implant Dentistry 4Health News:Anacapa Dental Art Institute Doctors Offers 6 Tips on How to Pay for Cosmetic, Restorative and Implant Dentistry 5Health News:Sonru Expansion continues with appointment of new executive team and opening of new London base 2
... Plan Members Drop Coverage for multiple Reasons; Integrated Retention Strategy ... Balance Sheet. , ... Orlando, FL ... of ConnextionsHealth provides both good and bad news for health ...
... U.S, NAPWA and POZ reinvigorate AIDS activism -WASHINGTON, March ... (NAPWA) and POZ magazine today announced the ... Principles Project. The project aims to encourage a ... self-empowerment manifesto written in 1983 by a group of ...
... Lead Lilly USA Business-to-Business Organization and Oversee Sales and ... Include Lilly USA Diabetes Business UnitINDIANAPOLIS, March 2 ... today announced that Alex M. Azar II, currently senior ... the top leadership role in Lilly,s U.S. Business-to-Business organization. ...
... its part to help fight AIDS in Africa with ... of National Sleep Awareness Week, Coherence Resources, Inc. provided ... they need: adequate sleep. Malaria medications taken by ... from Coherence Resources helps the volunteers cope with the ...
... Milan, Italy----Cowen and Company 29th Annual Health Care Conference in ... (Nasdaq: TSPT ) announced today that the Company ... , Glenn A. Oclassen, ... 2009, to be held at the Milano Convention Centre (MIC) ...
... Industries, Inc. (Nasdaq: HRLY ) announced today that ... $1 million from the U. S. Air Force for the ... The awards are for the production of transmit microwave assemblies ... components for use in the APG-68 radar system on various ...
Cached Medicine News:Health News:Common Approaches to Member Retention by Health Insurance Plans are Ineffective, New Study Shows 2Health News:Common Approaches to Member Retention by Health Insurance Plans are Ineffective, New Study Shows 3Health News:The National Association of People with AIDS (NAPWA) and POZ Magazine Partner to Launch The Denver Principles Project 2Health News:The National Association of People with AIDS (NAPWA) and POZ Magazine Partner to Launch The Denver Principles Project 3Health News:Lilly Announces Leadership Changes 2Health News:Lilly Announces Leadership Changes 3Health News:Sleepless in Botswana 2Health News:Sleepless in Botswana 3Health News:Transcept Pharmaceuticals to Present at Two Upcoming Conferences 2Health News:Transcept Pharmaceuticals to Present at Two Upcoming Conferences 3Health News:Herley Lancaster Awarded $1.0 Million in New Contracts 2
(Date:11/26/2014)... and LONDON , Nov. 25, ... AstraZeneca (NYSE: AZN ) today announced that AMAGINE-2 ... doses of brodalumab in more than 1,800 patients with moderate-to-severe ... Stelara ® (ustekinumab) and placebo at week 12. Brodalumab ... analysis group were each shown to be superior to Stelara ...
(Date:11/26/2014)... China, Nov. 26, 2014 China Nepstar Chain ... "Company"), a leading retail drugstore chain in China based ... its unaudited financial results for the third quarter ended September ... 30, 2014: , Same store sales increased by ... , Revenue increased by 8.1% to RMB738.3 million (US$120.3 million) ...
(Date:11/24/2014)... 24, 2014 Luoxis Diagnostics, Inc., a ... today announced the presentation of three clinical and ... a broadly applicable and robust research tool capable ... in response to injury, illness, or stress.  In ... with Luoxis, academic and pharmaceutical research partners, RedoxSYS ...
Breaking Medicine Technology:Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 2Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 3Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 4Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 5Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 6Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 7Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 8Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 9Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 10China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 2China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 3China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 4China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 5China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 6China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 7China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 8China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 9China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 10China Nepstar Chain Drugstore Ltd. Reports Third Quarter 2014 Financial Results 11Luoxis Announces Presentation of Multiple Studies Validating RedoxSYS as a Rapid and Non-invasive Means of Assessing Oxidative Stress 2Luoxis Announces Presentation of Multiple Studies Validating RedoxSYS as a Rapid and Non-invasive Means of Assessing Oxidative Stress 3Luoxis Announces Presentation of Multiple Studies Validating RedoxSYS as a Rapid and Non-invasive Means of Assessing Oxidative Stress 4Luoxis Announces Presentation of Multiple Studies Validating RedoxSYS as a Rapid and Non-invasive Means of Assessing Oxidative Stress 5
... According to Millennium Research Group (MRG), the global authority ... device market was valued at $41 million in 2010, ... awareness of health issues surrounding obesity, coupled with an ... will drive significant growth in the gastric band market ...
... 28 Decision Resources, one of the world,s ... healthcare issues, finds that oncologists will be the ... specialties because of their lower clinical trial requirements. ... Physician Perspectives on Biosimilar G-CSFs and ...
Cached Medicine Technology:While Ethicon Endo-Surgery and Allergan Remain Front-Runners in the $41 Million Gastric Band Market, Other Competitors Battle for Third Place, According to Millennium Research Group 2Oncologists Will Be More Aggressive In Adopting Biosimilars Compared With Other Specialties 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: